Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
filingDate |
2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19368948960ddeac036bb7ed8be65477 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_234ae75edcdfed55b2c7c2e4857bd88c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45dc8d1d9f2eacf9261209d374179004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d5b7543d53e67c6f537941002ba0c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7198df06de3b145b2a01c007d3c9d9be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63cbfbae981db9a83d4e0e0f7e15a7cb |
publicationDate |
2009-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7528163-B2 |
titleOfInvention |
Ophthalmic compositions for treating ocular hypertension |
abstract |
This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraocular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299079-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8455494-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298335-A1 |
priorityDate |
2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |